We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+6.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$32.4B
AUM Growth
+$1.3B
(+4.2%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-1.89%
Top 10 Holdings %
Top 10 Hldgs %
20.55%
Holding
2,157
New
184
Increased
710
Reduced
919
Closed
201
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Mills
GIS
|
+$167M |
| 2 |
Chevron
CVX
|
+$114M |
| 3 |
AT&T
T
|
+$89.6M |
| 4 |
Kinder Morgan
KMI
|
+$71.1M |
| 5 |
Lumen
LUMN
|
+$45.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$206M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$156M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 4 |
Halliburton
HAL
|
+$136M |
| 5 |
Johnson & Johnson
JNJ
|
+$130M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.55% |
| 2 | Consumer Staples | 14.38% |
| 3 | Financials | 9.62% |
| 4 | Utilities | 8.65% |
| 5 | Technology | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBD
1201
DELISTED
Diebold Nixdorf Incorporated
DBD
| $946K | ﹤0.01% |
27,311
-13,234
| -33% | -$467K |
|
1202
Ecolab
ECL
$76.8B
| $944K | ﹤0.01% |
9,032
+548
| +6% | +$59.9K |
|
1203
Louisiana-Pacific
LPX
$4.57B
| $944K | ﹤0.01% |
56,976
+963
| +2% | +$14.4K |
|
1204
Delek US
DK
$4.85B
| $939K | ﹤0.01% |
34,408
-14,630
| -30% | -$443K |
|
1205
Ceragon Networks
CRNT
$187M
| $936K | ﹤0.01% |
926,600
-1,073,400
| -54% | -$1.54M |
|
|
QVCGA
1206
DELISTED
QVC Group Inc Series A
QVCGA
| $933K | ﹤0.01% |
653
-472
| -42% | -$620K |
|
|
ADVS
1207
DELISTED
Advent Software Inc
ADVS
| $933K | ﹤0.01% |
30,437
+17,796
| +141% | +$568K |
|
1208
PC Connection
CNXN
$2.2B
| $930K | ﹤0.01% |
37,899
+687
| +2% | +$15.8K |
|
1209
CME Group
CME
$98B
| $928K | ﹤0.01% |
10,467
-725
| -6% | -$61.4K |
|
1210
ACI Worldwide
ACIW
$5.21B
| $923K | ﹤0.01% |
45,774
-26,984
| -37% | -$514K |
|
1211
Principal Financial Group
PFG
$25B
| $913K | ﹤0.01% |
17,564
+2,075
| +13% | +$108K |
|
1212
Copa Holdings
CPA
$5.23B
| $909K | ﹤0.01% |
8,770
-24,386
| -74% | -$2.59M |
|
1213
Alcoa
AA
$12.2B
| $906K | ﹤0.01% |
23,886
+36
| +0.2% | +$1.4K |
|
|
HAR
1214
DELISTED
Harman International Industries
HAR
| $896K | ﹤0.01% |
8,402
-9,786
| -54% | -$1.01M |
|
1215
Vertex Pharmaceuticals
VRTX
$130B
| $891K | ﹤0.01% |
7,503
+2,650
| +55% | +$298K |
|
1216
Host Hotels & Resorts
HST
$14.9B
| $885K | ﹤0.01% |
37,222
+2,774
| +8% | +$63.1K |
|
1217
Newmont
NEM
$128B
| $884K | ﹤0.01% |
46,784
+6,140
| +15% | +$124K |
|
1218
H&R Block
HRB
$5.56B
| $882K | ﹤0.01% |
26,168
-13,169
| -33% | -$422K |
|
1219
Omnicom Group
OMC
$21.8B
| $882K | ﹤0.01% |
11,385
-9,669
| -46% | -$705K |
|
1220
Owens Corning
OC
$10B
| $877K | ﹤0.01% |
24,500
| – | – |
|
|
NPKI
1221
NPK International
NPKI
$1.1B
| $876K | ﹤0.01% |
91,818
+86,611
| +1,663% | +$920K |
|
1222
Constellation Brands
STZ
$21B
| $870K | ﹤0.01% |
8,866
+3,983
| +82% | +$365K |
|
|
MRC
1223
DELISTED
MRC Global
MRC
| $866K | ﹤0.01% |
57,194
| – | – |
|
|
KITE
1224
DELISTED
Kite Pharma, Inc.
KITE
| $865K | ﹤0.01% |
15,000
-15,000
| -50% | -$632K |
|
|
PFC
1225
DELISTED
Premier Financial Corp. Common Stock
PFC
| $859K | ﹤0.01% |
50,432
+1,546
| +3% | +$23.4K |
|
Similar funds
Federated Hermes's Q4 2014 Portfolio in Review
As of Q4 2014, Federated Hermes held 2,157 positions worth $32.4B, up 4.2% from $31.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Federated Hermes's Q4 2014 filing shows 184 new, 710 increased, 919 reduced and 201 closed positions. Its largest new stake was Dynegy Inc.: 358,499 shares worth $36.6M. The largest sale was Eli Lilly, an estimated $206M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Consumer Staples and Financials.
- Federated Hermes's largest Q4 2014 buy was Dynegy Inc.: 358,499 shares worth $36.6M.
- Federated Hermes added most to General Mills in Q4 2014, an estimated $167M increase.
- Federated Hermes's biggest Q4 2014 reduction was Eli Lilly, cutting an estimated $206M.
- Federated Hermes fully exited Core Laboratories in Q4 2014, selling an estimated $46.8M.
- Federated Hermes's ten largest holdings make up 21% of its $32.4B portfolio in Q4 2014.
- Federated Hermes opened 184 new positions and closed 201 in Q4 2014.
- Federated Hermes's portfolio value rose 4.2% quarter-over-quarter to $32.4B.
Based on Federated Hermes's 13F filing for Q4 2014, filed 10 Feb 2015.